Bridgefront Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bridgefront Capital’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,644	Closed	-$254K	–	826
2024 Q3	$254K	Buy	+3,644	New	+$250K	0.1%	382
2024 Q1	–	Sell	-6,144	Closed	-$382K	–	586
2023 Q4	$382K	Sell	6,144 -2,087	-25%	-$117K	0.29%	125
2023 Q3	$462K	Buy	8,231 +3,006	+58%	+$169K	0.32%	87
2023 Q2	$264K	Buy	+5,225	New	+$278K	0.14%	300
2021 Q3	–	Sell	-3,637	Closed	-$231K	–	713
2021 Q2	$231K	Buy	+3,637	New	+$215K	0.09%	449

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bridgefront Capital's AXNX Position: Q4 2024 in Review

Bridgefront Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 3,644 shares — an estimated $254K sold.

Bridgefront Capital first reported a position in AXNX in Q2 2021 and held it in 5 quarters. The position peaked at $462K in Q3 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Bridgefront Capital reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Bridgefront Capital sold 3,644 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $254K.
Bridgefront Capital first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Bridgefront Capital's Axonics, Inc. Common Stock position peaked at $462K in Q3 2023.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Bridgefront Capital's 13F filing for Q4 2024, filed 14 Feb 2025.